Crestwood Advisors Group’s Eastman Chemical EMN Stock Holding History

Crestwood Advisors Group’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-160	Closed	-$13K	–	237
2017 Q1	$13K	Buy	+160	New	+$12.6K	﹤0.01%	414

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Crestwood Advisors Group's EMN Position: Q2 2017 in Review

Crestwood Advisors Group sold out of Eastman Chemical (EMN) in Q2 2017, closing a stake of 160 shares — an estimated $13K sold.

Crestwood Advisors Group first reported a position in EMN in Q1 2017 and held it in 1 quarter. The position peaked at $13K in Q1 2017. 618 funds tracked by Wall St. Rank hold EMN as of Q2 2017.

Crestwood Advisors Group reported no remaining Eastman Chemical position as of Q2 2017 after selling out during the quarter.
Crestwood Advisors Group sold 160 Eastman Chemical shares in Q2 2017, an estimated $13K.
Crestwood Advisors Group first reported a position in Eastman Chemical in Q1 2017 and held it in 1 quarter.
Crestwood Advisors Group's Eastman Chemical position peaked at $13K in Q1 2017.
618 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2017.

Based on Crestwood Advisors Group's 13F filing for Q2 2017, filed 31 Jul 2017.